5.60
Schlusskurs vom Vortag:
$5.68
Offen:
$5.65
24-Stunden-Volumen:
207.31K
Relative Volume:
0.74
Marktkapitalisierung:
$148.61M
Einnahmen:
$351.50M
Nettoeinkommen (Verlust:
$-24.90M
KGV:
-6.1109
EPS:
-0.9164
Netto-Cashflow:
$-10.24M
1W Leistung:
-3.61%
1M Leistung:
-12.50%
6M Leistung:
-3.28%
1J Leistung:
-24.02%
Inogen Inc Stock (INGN) Company Profile
Firmenname
Inogen Inc
Sektor
Branche
Telefon
805-562-0500
Adresse
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
INGN
Inogen Inc
|
5.60 | 150.74M | 351.50M | -24.90M | -10.24M | -0.9164 |
|
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | B. Riley Securities | Buy |
| 2025-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-02-15 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-07-14 | Herabstufung | Needham | Buy → Hold |
| 2023-01-17 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | Hochstufung | Needham | Hold → Buy |
| 2021-11-02 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | Herabstufung | Needham | Buy → Hold |
| 2020-05-06 | Bestätigt | Needham | Buy |
| 2019-11-06 | Hochstufung | Needham | Hold → Buy |
| 2019-09-13 | Bestätigt | Piper Jaffray | Overweight |
| 2019-08-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | Herabstufung | Stifel | Buy → Hold |
| 2019-08-07 | Herabstufung | Needham | Buy → Hold |
| 2019-06-28 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-05-08 | Bestätigt | Needham | Strong Buy |
| 2019-02-27 | Bestätigt | Needham | Strong Buy |
| 2018-11-20 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-11-07 | Bestätigt | Needham | Buy |
| 2018-09-10 | Herabstufung | Needham | Strong Buy → Buy |
| 2018-08-22 | Fortgesetzt | Stifel | Buy |
| 2018-08-08 | Bestätigt | Needham | Strong Buy |
| 2018-06-06 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | Bestätigt | Needham | Strong Buy |
| 2018-02-28 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Inogen Inc Aktie (INGN) Neueste Nachrichten
Inogen (INGN) Shares: Ends Higher by 2.05% at $5.71 in the Current Update; Price Setup: the Supplied Trading Band Runs From $5.42 to $6.00 in the Latest SessionDescending Triangle - Vinanet
Top 3 Health Care Stocks That Could Blast Off This Month - Sahm
CPAP Store USA Adds New Inogen Aurora CPAP Mask Line - Sleep Review
Inogen (INGN) Cuts Guidance Even As Profitability Climbs - Yahoo Finance
Dimensional Fund Advisors LP Reduces Position in Inogen, Inc $INGN - MarketBeat
Inogen Inc. Earnings Call Balances Growth and Caution - TipRanks
Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists - Yahoo Finance
Should Investors Buy Inogen as Low Valuation Meets Execution Risk? - Yahoo Finance
Inogen Launches First CPAP Mask Portfolio - respiratory-therapy.com
Inogen Launches Voxi 5 Stationary Oxygen Concentrator - respiratory-therapy.com
Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut - TradingView
Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$12.67 - simplywall.st
Inogen (NASDAQ:INGN) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Inogen (INGN) Has a New Rating from B. Riley Securities - The Globe and Mail
Inogen Inc (6IO.SG) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Q2 2026 Inogen, Inc. Earnings Call Transcript - GuruFocus
Inogen Q2 2026 slides: international growth offsets U.S. weakness By Investing.com - Investing.com South Africa
Inogen Inc Q2 2026: Revenue $95.08M, EPS $(0.14) — 10-Q Summary - TradingView
Inogen (NASDAQ: INGN) posts Q2 2026 revenue growth but stays unprofitable - Stock Titan
Inogen, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
INGN Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares SlipEarnings Outlook Update - Vinanet
Inogen Inc (INGN) (Q2 2026) Earnings Call Highlights: Strong Int - GuruFocus
Inogen, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:INGN) 2026-08-06 - Seeking Alpha
Inogen Q2 Earnings Call Highlights - marketbeat.com
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Is Inogen Inc (INGN) Undervalued After Q2 Earnings Miss? EPS at -$0.15, Revenue at $95.1M, GF Score: 66/100 - GuruFocus
Inogen Inc earnings beat by $0.03, revenue topped estimates - Investing.com
Inogen, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Inogen (NASDAQ:INGN) Falls as Revenue Misses and Full-Year Guidance Trails Estimates - ChartMill
Inogen, Inc. Revises Earnings Guidance for Full Year 2026 - marketscreener.com
Inogen: Q2 Earnings Snapshot - marketscreener.com
Inogen posts Q2 2026 revenue $95.1M, raises full-year adjusted EBITDA guidance to ~$4.0M - TradingView
Tranche Update on Inogen, Inc.'s Equity Buyback Plan announced on February 24, 2026. - marketscreener.com
Inogen Announces Second Quarter 2026 Financial Results - Business Wire
Inogen, Inc. expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Arrowstreet Capital Limited Partnership Acquires 393,310 Shares of Inogen, Inc $INGN - marketbeat.com
Inogen (NASDAQ:INGN) Stock Crosses Below 200-Day Moving AverageHere's What Happened - MarketBeat
Inogen, Inc Revenue Breakdown – NASDAQ:INGN - TradingView
Inogen Inc (INGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inogen Inc (INGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inogen Inc (INGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inogen Inc (INGN) Institutional Confidence - TradingKey
Inogen Inc (INGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inogen Inc (INGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inogen Inc (INGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Inogen Inc (INGN) Surges 3.28% as Shares Test Key Resistance LevelsTake Profit Levels - Vinanet
INGN|Inogen Inc|Price:6.150|Chg%:-0.170 - TradingKey
Inogen Inc (INGN) Balance Sheet - TradingKey
TradingKey - TradingKey
Inogen (INGN) Slides 2.7% as Stock Tests Key Support LevelsSentiment Extreme - Vinanet
Inogen Inc (INGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Finanzdaten der Inogen Inc-Aktie (INGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):